Debt-to-equity of ELITE PHARMACEUTICALS INC /NV/ from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly Debt-to-equity in % history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • ELITE PHARMACEUTICALS INC /NV/ Debt-to-equity for the quarter ending 31 Dec 2025 was 86%, a 13% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 86% +10% +13% 31 Dec 2025
Q3 2025 109% +49% +82% 30 Sep 2025
Q2 2025 109% +56% +106% 30 Jun 2025
Q1 2025 86% +32% +60% 31 Mar 2025
Q4 2024 76% +21% +38% 31 Dec 2024
Q3 2024 60% +2.7% +4.7% 30 Sep 2024
Q2 2024 53% -11% -17% 30 Jun 2024
Q1 2024 54% -18% -25% 31 Mar 2024
Q4 2023 55% -18% -24% 31 Dec 2023
Q3 2023 57% -7.4% -12% 30 Sep 2023
Q2 2023 64% +8.5% +15% 30 Jun 2023
Q1 2023 72% +25% +54% 31 Mar 2023
Q4 2022 72% +20% +39% 31 Dec 2022
Q3 2022 64% +3.9% +6.5% 30 Sep 2022
Q2 2022 55% -15% -21% 30 Jun 2022
Q1 2022 46% -40% -46% 31 Mar 2022
Q4 2021 52% -51% -50% 31 Dec 2021
Q3 2021 60% -66% -52% 30 Sep 2021
Q2 2021 70% -134% -66% 30 Jun 2021
Q1 2021 86% -280% -76% 31 Mar 2021
Q4 2020 103% -3102% -97% 31 Dec 2020
Q3 2020 126% +785% 30 Sep 2020
Q2 2020 204% +1937% 30 Jun 2020
Q1 2020 366% -1978% -84% 31 Mar 2020
Q4 2019 3205% +2678% +508% 31 Dec 2019
Q3 2019 -659% -968% -313% 30 Sep 2019
Q2 2019 -1733% -1975% -816% 30 Jun 2019
Q1 2019 2344% +2088% +813% 31 Mar 2019
Q4 2018 527% +409% +348% 31 Dec 2018
Q3 2018 310% +234% +307% 30 Sep 2018
Q2 2018 242% +181% +298% 30 Jun 2018
Q1 2018 257% +144% +128% 31 Mar 2018
Q4 2017 118% +509% 31 Dec 2017
Q3 2017 76% +154% 30 Sep 2017
Q2 2017 61% +120% 30 Jun 2017
Q1 2017 113% +179% 31 Mar 2017
Q4 2016 -391% -322% -465% 31 Dec 2016
Q3 2016 -78% +34% +31% 30 Sep 2016
Q2 2016 -59% +71% +55% 30 Jun 2016
Q1 2016 -66% +65% +50% 31 Mar 2016
Q4 2015 -69% +70% +50% 31 Dec 2015
Q3 2015 -112% +28% +20% 30 Sep 2015
Q2 2015 -130% +18% +12% 30 Jun 2015
Q1 2015 -131% +40% +23% 31 Mar 2015
Q4 2014 -139% +182% +57% 31 Dec 2014
Q3 2014 -140% +108% +44% 30 Sep 2014
Q2 2014 -148% +38% +20% 30 Jun 2014
Q1 2014 -172% -8.5% -5.2% 31 Mar 2014
Q4 2013 -321% -165% -105% 31 Dec 2013
Q3 2013 -248% -93% -60% 30 Sep 2013
Q2 2013 -185% -31% -20% 30 Jun 2013
Q1 2013 -163% -16% -11% 31 Mar 2013
Q4 2012 -156% -9.5% -6.5% 31 Dec 2012
Q3 2012 -155% 30 Sep 2012
Q2 2012 -155% 30 Jun 2012
Q1 2012 -147% 31 Mar 2012
Q4 2011 -147% 31 Dec 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.